The Board remands the claim for service connection for acute myelogenous leukemia due to an inadequate medical opinion and a need to address direct service connection.
The deciding factor: The June 2023 TERA medical opinion was found inadequate as it did not provide a reasoned medical explanation connecting the Veteran's acute myelogenous leukemia to his in-service toxic exposures or address whether the condition had onset during service.
- Claimed conditions
- Acute myelogenous leukemia
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- None in this decision
- Decision date
- April 8, 2025
- Citation
- A25032090
Veterans Law Judge
Decisions by this judge: 2,451 · Granted: 22% (granted or partly granted, in the vetted decisions on this site)
Judge attribution: 2025 complete; earlier years partial.
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation A25032090.
What this means for you
A remand is not a loss. The Board sent the case back for more development — often a new exam or missing records — before making a final decision. Many remands later end in a grant, and the decision spells out exactly what the Board wanted to see.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Granted
The Veteran's acute myelogenous leukemia is granted as service connected due to in-service herbicide exposure, with the Board finding that his condition was likely caused by this exposure.
- Denied
The VA withheld compensation benefits to recoup separation pay in the amount of $17,513.28 due to a statutory requirement and the decision is denied as it was proper.
- Granted
The Board has determined that the Veteran's diagnosed acute myelogenous leukemia is at least as likely as not related to his active service, including exposure to chemicals released from burn pits during his deployment in Afghanistan.
- Remanded (sent back)
The Veteran's appeal is remanded for additional development, including a VA examination to assess the severity of his service-connected acute myelogenous leukemia and its residuals. The TDIU claim is also remanded for consideration on both schedular and extraschedular grounds.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.